Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

MIP Technologies Presents New Range of RENSA™ Industrial Resins

Published: Monday, January 27, 2014
Last Updated: Monday, January 27, 2014
Bookmark and Share
New range of polymeric separation resins for industrial use.

MIP Technologies has presented a new range of RENSA™ industrial resins. The company is now offering industrial resin products together with recently published product- and application notes on the website http://www.biotage.com/product-page/rensa-bulk-resins.

These notes describe the materials and physical properties as well as the performance of the new resins so that customers can select the appropriate resin for their specific separation requirements.

“The food, beverage, pharma, consumer products and life science industries are constantly confronted with new separation challenges as the result of an ever changing regulatory environment and the pressure to achieve a better process economy. In response to this need, MIP Technologies has established a broad range of polymeric materials spanning a wide chemistry landscape that will enable these industries to overcome those separation challenges” says Dr. Ecevit Yilmaz, Product Manager – Industrial Resins.

Dr. Yilmaz continued, “The separation materials can be used by our customers at the pilot and production scale to either extract undesired impurities or to enrich specific target compounds from complex matrices.”

“The area of Industrial Scale applications is an important new pillar in the business of Biotage. We will continue to invest into the development of our Industrial Resin portfolio and we will further expand the range of engineered polymeric adsorbents. This will allow us to offer unique and highly selective separation solutions to our wide range of industrial customers” says Dr. Ecevit Yilmaz.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Madison Researchers Begin Work on Zika Virus
Work will start with basic questions about Zika virus infection.
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable
Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.
Drug that Activates Innate Immune System Identified
Researchers from the institute have identified a drug, which is straightforward to synthesize and to couple to antigens that induce an immune response and may prove useful in the generation of vaccines.
Valvena, GSK Sign New R&D Collaboration
Valneva to supply process development services for EB66® -based Influenza vaccines.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Protein Protects Against Flu in Mice
The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!